Skip to Main Content

Vice Chancellor Roger M. Wakimoto Announces a 30-Day Public Review Period for UCLA Administrative Policies 916 and 917

On October 21, 2021, Vice Chancellor for Research & Creative Activities Roger Wakimoto and UCLA Health announced via a BruinPost a 30-day public review and comment period for two new policies: 

  • UCLA Policy 916: Protocol Review and Approval by an Independent Scientific Review Committee for Clinical Trials
  • UCLA Policy 917: Good Clinical Practice Training and Certification

VC Wakimoto encourages faculty and staff to review these new policies and submit comments via the webpage by November 22, 2021

Any questions about the policy process can be directed to Anna Joyce at